Ventricular arrhythmia
Conditions
Interventions
Ventricular arrhythmia of the outflow tract:Using pulsed electric fields to ablate ventricular arrhythmias.
Sponsors
Fu Wai Hospital, Chinese Academy of Medical Sciences, Fu Wai, China
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.18 years old 10,000 beats/24h or symptomatic premature beats on ambulatory electrocardiography), who are proposed to undergo catheter-based ablation therapy; 3.Those who agreed to participate in this study and voluntarily signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with other symptomatic arrhythmias such as polygenic premature ventricular beats/ventricular tachycardia requiring pharmacologic control; 2.Patients with a previous history of ventricular fibrillation (VF); 3.Patients with atrial pre-systole, atrial tachycardia, atrial fibrillation, supraventricular tachycardia, and other symptomatic arrhythmias requiring pharmacologic control; 4.Patients with myocardial infarction or unstable angina within 90 days; 5.Patients who have undergone cardiac surgery or percutaneous coronary intervention PCI.within 90 days; 6.Patients with left ventricular ejection fraction LVEF. 2 times the upper limit of normal values); 11.Clinically significant mitral stenosis or regurgitation, any heart valve prolapse, or after valve replacement; 12.Patients with severe restrictive or obstructive lung disease or chronic respiratory disease that, in the judgment of the investigator, precludes cardiac surgery; 13.Patients with severe gastrointestinal bleeding; 14.Presence of a left ventricular assist device LVAD.or planned LVAD or heart transplantation; 15.Patients with life expectancy of less than 1 year, such as a history of malignant tumors and end-stage diseases; 16.Females who are pregnant or breastfeeding or who are planning to have a baby during the study period; 17.Patients who are participating in clinical trials of other drugs or medical devices; 18.Patients who, in the opinion of the investigator, are not suitable for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute Success Rate; | — |
Countries
China
Contacts
Public ContactYan Yao
Fu Wai Hospital, Chinese Academy of Medical Sciences, Fu Wai, China
Outcome results
None listed